Central Serous Chorioretinopathy
Central Serous Chorioretinopathy
Central Serous Chorioretinopathy usually, but not always, resolves without treatment after a few months with a full recovery of the diminished central vision. Serous means that the fluid is thin and watery. About one-third to one-half patients who have a Central Serous Chorioretinopathy has a recurrence after the first episode of the problem. The recurrence is within one year of the first episode, but relapses may occur up to ten years later.Symptoms of Central Serous Chorioretinopathy
Many patients first notice a minor blurring of vision, followed by various degrees of “metamorphopsia” or distorted vision, “micropsia” or the perception that objects are smaller than they actually are, “chromatopsia” or objects looking unusually colored and a shift of prescription toward farsightedness or hyperopia. Visual acuity may range from 20/20 to 20/200 and averages 20/30. In some patients the onset of symptoms is preceded or accompanied by migraine-like headaches.
Treatment of Central Serous Chorioretinopathy
Although no medication has thus far proved effective in treating Central Serous Chorioretinopathy and the condition will resolve on its own, a beneficial effect of Laser Photocoagulation Treatment has been reported in several studies. It is believed that although direct photocoagulation of the leakage point does not improve the final level of vision, it can shorten the acute phase of the disease and also lower the recurrence rate to about one fifth of what would be expected without active treatment.